Autopsy report · NCT02751424

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study data is currently under review.”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 8 months before it stopped.
62 participants enrolled.
Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: GlaxoSmithKline
Sponsor type: Industry
Conditions: Infections, Bacterial
Interventions: GSK3342830; Placebo
Participants: 62
Sites: 1
Countries: Australia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.